Amerityre Develops New Urethane-Based Kryon Material for Forklift Tire Industry

Amerityre Corporation, (OTC Bulletin Board: AMTY) a leading manufacturer of polyurethane flat proof tires, today announced that Amerityre Corporation has developed a NEW innovative high performance material formulation for the forklift tire industry.

The NEW urethane based material "KRYON" is designed to carry today's heavy material handling loads in high duty cycle forklift applications.

The industrial tire market globally is about 1 billion dollars. Amerityre has plans to capture a substantial piece of the North American market estimated to be $270 million within the next several years.

Tim Ryan, Amerityre's new Chairman, has said, "This is the newest breakthrough in the forklift tire industry in over 100 years! The market is right for a new product that will outperform current rubber products in the market place today. The Amerityre Forklift tires are made with a special formulation we call Kryon®."

"Independent lab testing and field testing has been ongoing for over one year with great success," said Mike Kapral, Amerityre's President/CEO. "Tires were placed in specific high load and high cycle applications where the tires can get a real world workout."

Amerityre will offer approximately 30 of the most popular sizes of press-on tires with plans to expand the line-up over the next 18 months. Amerityre has plans to design and produce a line of pneumatic shaped solid tires for forklift as well.

Amerityre is selling press-on tires now through a limited testing/distribution program. We have an increasing demand for the product everyday as the word on the outstanding performance of the tire reaches customers.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.